Literature DB >> 8360392

Bronchial epithelial cells of patients with asthma release chemoattractant factors for T lymphocytes.

A Bellini1, H Yoshimura, E Vittori, M Marini, S Mattoli.   

Abstract

BACKGROUND: T lymphocytes may orchestrate the inflammatory response in atopic asthma, but the mechanisms that promote T-cell accumulation in asthmatic airways are still unclear. In this study, we tested the hypothesis that bronchial epithelial cells of patients with atopic asthma release chemoattractant factors for T lymphocytes.
METHODS: Sixteen patients with atopic asthma and eight healthy control subjects were selected for this study. Bronchial epithelial cells were isolated from biopsy specimens obtained by means of bronchoscopy and cultured for 48 hours in serum- and hormone-free medium, with or without 10(-6) mol/L histamine.
RESULTS: Only the supernatants of cells from donors with asthma showed chemotactic activity for T lymphocytes, and this was significantly increased (p < 0.025) by exposure to histamine. Chemotactic activity was in part mediated by interleukin-8 (IL-8), because an antibody against human IL-8 significantly reduced it (p < 0.05) and the cell supernatants contained appreciable amounts of immunoreactive IL-8 (0.89 +/- 0.39 ng/ml). Both the residual chemotactic activity of unstimulated epithelial cells and the increased activity caused by histamine were mediated by a single protease-sensitive substance with an apparent molecular weight of 56,000 d and an estimated isoelectric point of 8.8 to 9.1. The partially purified chemoattractant specifically enhanced the migration of CD4+ T lymphocytes, and its activity was inhibited by the univalent Fab fragment of a monoclonal antibody against CD4.
CONCLUSION: These results extend our previous observations, indicating an important effector role of bronchial epithelium in asthma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8360392     DOI: 10.1016/0091-6749(93)90120-5

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  15 in total

1.  Increased levels of interleukin-16 in the airways of tobacco smokers: relationship with peripheral blood T lymphocytes.

Authors:  M Laan; I Qvarfordt; G C Riise; B A Andersson; S Larsson; A Lindén
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

Review 2.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 3.  Whipple's disease: a macrophage disease.

Authors:  Benoît Desnues; Melanie Ihrig; Didier Raoult; Jean-Louis Mege
Journal:  Clin Vaccine Immunol       Date:  2006-02

4.  Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes.

Authors:  N L Mathy; W Scheuer; M Lanzendörfer; K Honold; D Ambrosius; S Norley; R Kurth
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

5.  Prevalence of the -295 T-to-C promoter polymorphism of the interleukin (IL)-16 gene in periodontitis.

Authors:  M Folwaczny; J Glas; H-P Török; L Tonenchi; E Paschos; O Malachova; B Bauer; C Folwaczny
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

6.  Sec14l3 is specifically expressed in mouse airway ciliated cells.

Authors:  Lihua Shan; Shinobu Noritake; Masatoshi Fujiwara; Satoshi Asano; Chikako Yoshida-Noro; Nobuhiro Noro; Keizo Yamashita; Takao Kawakami
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

7.  Human B-cell lines constitutively express and secrete interleukin-16.

Authors:  V Sharma; J L Sparks; J D Vail
Journal:  Immunology       Date:  2000-02       Impact factor: 7.397

8.  IL-16 in the airways of lung allograft recipients with acute rejection or obliterative bronchiolitis.

Authors:  M Laan; A Lindén; G C Riise
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

9.  IL-16 promotes T. whipplei replication by inhibiting phagosome conversion and modulating macrophage activation.

Authors:  Eric Ghigo; Abdoulaye Oury Barry; Lionel Pretat; Khatoun Al Moussawi; Benoît Desnues; Christian Capo; Hardy Kornfeld; Jean-Louis Mege
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

10.  Interleukin 16 (IL-16). IUIS/WHO Standing Committee on Interleukin Designation.

Authors: 
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.